We are live on ! Find out more
PCP

Perbak Capital Partners Portfolio holdings

AUM $406M
1-Year Est. Return 17.25%
This Fund
S&P 500
This Quarter Est. Return
+3.12%
1 Year Est. Return
+17.25%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$328M
AUM Growth
-$240M
Cap. Flow
-$246M
Cap. Flow %
-75.18%
Top 10 Hldgs %
66.9%
Holding
335
New
47
Increased
14
Reduced
158
Closed
116
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARW icon
201
Arrow Electronics
ARW
$11.1B
$224K 0.07%
+2,033
New +$231K
META icon
202
Meta Platforms (Facebook)
META
$1.42T
$222K 0.07%
+336
New +$224K
SAM icon
203
Boston Beer
SAM
$1.91B
$222K 0.07%
1,136
-58
-5% -$12K
STE icon
204
Steris
STE
$22.3B
$220K 0.07%
869
-1,696
-66% -$426K
AXSM icon
205
Axsome Therapeutics
AXSM
$11.2B
$220K 0.07%
1,202
-5,111
-81% -$714K
ALL icon
206
Allstate
ALL
$68B
$219K 0.07%
1,054
-1,642
-61% -$336K
TT icon
207
Trane Technologies
TT
$100B
$218K 0.07%
560
-1,671
-75% -$691K
EME icon
208
Emcor
EME
$35.2B
$217K 0.07%
354
-1,033
-74% -$669K
LHX icon
209
L3Harris
LHX
$51.6B
$216K 0.07%
736
-88
-11% -$25.4K
IDXX icon
210
Idexx Laboratories
IDXX
$44.1B
$216K 0.07%
319
-909
-74% -$619K
KVYO icon
211
Klaviyo
KVYO
$5.34B
$215K 0.07%
6,620
-3,774
-36% -$106K
CAI
212
Caris Life Sciences
CAI
$4.43B
$212K 0.06%
7,851
-2,852
-27% -$80.3K
VRNS icon
213
Varonis Systems
VRNS
$4.59B
$209K 0.06%
6,379
-7,942
-55% -$333K
TPR icon
214
Tapestry
TPR
$30.8B
$209K 0.06%
1,635
-2,079
-56% -$238K
DNLI icon
215
Denali Therapeutics
DNLI
$3.65B
$208K 0.06%
+12,611
New +$213K
CW icon
216
Curtiss-Wright
CW
$26.7B
$207K 0.06%
375
-934
-71% -$521K
KYMR icon
217
Kymera Therapeutics
KYMR
$8.51B
$205K 0.06%
2,638
-4,866
-65% -$329K
TXG icon
218
10x Genomics
TXG
$6B
$182K 0.06%
+11,167
New +$169K
FUBO icon
219
FuboTV Inc
FUBO
$261M
$58.4K 0.02%
+1,932
New +$77.1K
A icon
220
Agilent Technologies
A
$39.1B
-8,772
Closed -$1.13M
AAPL icon
221
Apple
AAPL
$4.54T
-1,989
Closed -$506K
ADT icon
222
ADT
ADT
$5.58B
-25,125
Closed -$219K
AME icon
223
Ametek
AME
$55.4B
-2,172
Closed -$408K
AMZN icon
224
Amazon
AMZN
$2.92T
-3,231
Closed -$709K
ANF icon
225
Abercrombie & Fitch
ANF
$4.42B
-11,777
Closed -$1.01M

Similar funds

Perbak Capital Partners's Q4 2025 Portfolio in Review

As of Q4 2025, Perbak Capital Partners held 335 positions worth $328M, down 42% from $568M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Perbak Capital Partners withdrew a net $246M in Q4 2025, closing 116 positions and reducing 158 holdings. Its most notable exit was State Street Health Care Select Sector SPDR ETF, an estimated $24.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 9.7% of assets, down from 12% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Perbak Capital Partners opened a new position in VanEck Oil Services ETF worth $18.5M.

  • Perbak Capital Partners's largest Q4 2025 buy was VanEck Oil Services ETF: 64,815 shares worth $18.5M.
  • Perbak Capital Partners added most to State Street SPDR S&P 500 ETF Trust in Q4 2025, an estimated $10.6M increase.
  • Perbak Capital Partners's biggest Q4 2025 reduction was State Street Industrial Select Sector SPDR ETF, cutting an estimated $32M.
  • Perbak Capital Partners fully exited State Street Health Care Select Sector SPDR ETF in Q4 2025, selling an estimated $24.1M.
  • Perbak Capital Partners's ten largest holdings make up 67% of its $328M portfolio in Q4 2025.
  • Perbak Capital Partners opened 47 new positions and closed 116 in Q4 2025.
  • Perbak Capital Partners's portfolio value fell 42% quarter-over-quarter to $328M.

Based on Perbak Capital Partners's 13F filing for Q4 2025, filed 17 Feb 2026.